Fibroblast growth factor-2 selectively stimulates angiogenesis of small vessels in arterial tree.

There is a critical need for quantifiable models of angiogenesis in vivo, and in general, differential effects of angiogenic regulators on vascular morphology have not been measured. Because the potent angiogenic stimulators fibroblast growth factor (FGF)-2 (basic FGF) and vascular endothelial growth factor (VEGF) are reported to stimulate angiogenesis through distinct signaling pathways, we hypothesized that FGF-2 stimulates vascular morphology differently than does VEGF and that stimulation of angiogenesis by FGF-2 is directly correlated to FGF receptor density. FGF-2 was applied at embryonic day 7 (E7), E8, or E9 to the quail chorioallantoic membrane (CAM); subsequent response of the arterial tree was measured by the fractal dimension (D(f)), a mathematical descriptor of complex spatial patterns, and by several generational branching parameters that included vessel length density (L(v)). After application of FGF-2 at E7, arterial density increased according to D(f) as a direct function of increasing FGF-2 concentration, and FGF-2 stimulated the growth of small vessels, but not of large vessels, according to L(v) and other branching parameters. For untreated control specimens at E7, L(v) of small vessels and D(f) were 11.1+/-1.6 cm(-1) and 1.38+/-0.01, respectively; at E8, after treatment with 5 microgram FGF-2/CAM for 24 hours, L(v) of small vessels and D(f) increased respectively to 22.8+/-0.7 cm(-1) and 1. 49+/-0.02 compared with 16.3+/-0.9 cm(-1) and 1.43+/-0.02 for PBS-treated control specimens. Application of FGF-2 at E8 and E9 did not significantly increase arterial density. By immunohistochemistry, the expression of 4 high-affinity tyrosine kinase FGF receptors was significantly expressed at E7, when CAM vasculature responded strongly to FGF-2 stimulation, but FGF receptor expression decreased throughout the CAM by E8, when vascular response to FGF-2 was negligible. In conclusion, the "fingerprint" vascular pattern elicited by FGF-2 was distinct from vascular patterns induced by other angiogenic regulators that included VEGF(165), transforming growth factor-beta1, and angiostatin.

[1]  S. Mandriota,et al.  Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. , 1997, Journal of cell science.

[2]  D. Fulgham,et al.  FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic mice. , 1999, Endothelium : journal of endothelial cell research.

[3]  G S Kassab,et al.  Morphometry of pig coronary arterial trees. , 1993, The American journal of physiology.

[4]  H. Rakowski,et al.  Effect of a single bolus of intracoronary basic fibroblast growth factor on perfusion in an ischemic porcine model. , 1999, Canadian Journal of Cardiology.

[5]  G S Kassab,et al.  Morphometry of the dog pulmonary venous tree. , 1993, Journal of applied physiology.

[6]  W. Risau,et al.  Induction of vasculogenesis and hematopoiesis in vitro. , 1992, Development.

[7]  S. Pawlowski,et al.  Fibroblast growth factor 2 control of vascular tone , 1998, Nature Medicine.

[8]  D. Ornitz,et al.  FGF signaling in skeletal development. , 1998, Frontiers in bioscience : a journal and virtual library.

[9]  David C. Lee,et al.  An essential role for ectodomain shedding in mammalian development. , 1998, Science.

[10]  D. Johnson,et al.  Structural and functional diversity in the FGF receptor multigene family. , 1993, Advances in cancer research.

[11]  R. Friesel,et al.  Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  J. Slavin,et al.  Fibroblast growth factors: at the heart of angiogenesis. , 1995, Cell biology international.

[13]  P. Campochiaro,et al.  Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. , 1998, The American journal of pathology.

[14]  P. Campochiaro,et al.  Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. , 1998, The American journal of pathology.

[15]  D. Rifkin,et al.  Fibroblast growth factors as angiogenesis factors: new insights into their mechanism of action. , 1997, EXS.

[16]  P. Maher,et al.  High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells--implications for the modulation of FGF-2 , 1995, The Journal of cell biology.

[17]  S. Bryant,et al.  Vascular remodeling in response to altered blood flow is mediated by fibroblast growth factor-2. , 1999, Circulation research.

[18]  P. Parsons-Wingerter,et al.  A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. , 1998, Microvascular research.

[19]  Chandra L. Theesfeld,et al.  Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  V. Sasisekharan,et al.  Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. S. Coffey.  Self-organization, complexity and chaos: The new biology for medicine , 1998, Nature Medicine.

[22]  Growth factor effects on cells of the vascular wall: a survey. , 1993, Growth factors.

[23]  B. Zetter,et al.  Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. , 1996, Growth factors.

[24]  Harold E. Dvorak,et al.  Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors , 1997, Thrombosis and Haemostasis.

[25]  P. Campochiaro,et al.  Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. , 1999, The American journal of pathology.

[26]  J. Douglas,et al.  Endothelial cell origin and migration in embryonic heart and cranial blood vessel development , 1991, The Anatomical record.

[27]  D. Rifkin,et al.  Biological roles of fibroblast growth factor-2. , 1997, Endocrine reviews.

[28]  H. Moses,et al.  Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane , 1990, The Journal of cell biology.

[29]  Rakesh K. Jain,et al.  Quantitative angiogenesis assays: Progress and problems , 1997, Nature Medicine.

[30]  R K Jain,et al.  Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. , 1996, The American journal of pathology.

[31]  G. Neufeld,et al.  Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  Lois E. H. Smith,et al.  Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Smith,et al.  Fibroblast growth factors and their receptors. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[34]  R. Jain,et al.  Cancer, angiogenesis and fractals , 1998, Nature Medicine.

[35]  G S Kassab,et al.  Morphometry of pig coronary venous system. , 1994, The American journal of physiology.

[36]  F. Dieterlen‐Lièvre,et al.  Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells. , 1987, Development.

[37]  T L Blundell,et al.  Fibroblast growth factor receptors: lessons from the genes. , 1998, Trends in biochemical sciences.

[38]  N. Ling,et al.  Identification of soluble forms of the fibroblast growth factor receptor in blood. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[39]  F. Walsh,et al.  Promiscuity of fibroblast growth factor receptors , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[40]  D. Givol,et al.  Complexity of FGF receptors: genetic basis for structural diversity and functional specificity , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  J. Gabriel,et al.  Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex. , 1999, Biochemistry.

[42]  D. Fernig,et al.  Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. , 1994, Progress in growth factor research.

[43]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[44]  D. Donoghue,et al.  FGFR activation in skeletal disorders: too much of a good thing. , 1997, Trends in genetics : TIG.

[45]  C. Little,et al.  Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[46]  P. Parsons-Wingerter,et al.  Generational analysis reveals that TGF-beta1 inhibits the rate of angiogenesis in vivo by selective decrease in the number of new vessels. , 2000, Microvascular research.

[47]  G. Dorn,et al.  Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. , 1995, Molecular biology of the cell.

[48]  L. Aiello,et al.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.